You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?

Authors

Citation

Harrold L, Litman H, Connolly S, et al
AB0213 Is Disease Duration An Independent Predictor of Low Disease Activity/remission among Biologic-Naïve Patients with Rheumatoid Arthritis Treated with Abatacept?
Annals of the Rheumatic Diseases 2016;75:970.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions